These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography. Eggers C; Kahraman D; Fink GR; Schmidt M; Timmermann L Mov Disord; 2011 Feb; 26(3):416-23. PubMed ID: 21264942 [TBL] [Abstract][Full Text] [Related]
4. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT. Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760 [TBL] [Abstract][Full Text] [Related]
5. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study. Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904 [TBL] [Abstract][Full Text] [Related]
6. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease. Song IU; Chung YA; Oh JK; Chung SW Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629 [TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum. Eggers C; Schwartz F; Pedrosa DJ; Kracht L; Timmermann L PLoS One; 2014; 9(5):e96629. PubMed ID: 24848641 [TBL] [Abstract][Full Text] [Related]
8. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease. Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205 [TBL] [Abstract][Full Text] [Related]
10. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298 [TBL] [Abstract][Full Text] [Related]
11. Relations of clinical symptoms with dopamine transporter imaging in drug-naïve Parkinson's disease. Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y Clin Neurol Neurosurg; 2020 Sep; 196():105960. PubMed ID: 32593043 [TBL] [Abstract][Full Text] [Related]
12. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease. Eshuis SA; Maguire RP; Leenders KL; Jonkman S; Jager PL Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235 [TBL] [Abstract][Full Text] [Related]
13. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using Cascianelli S; Tranfaglia C; Fravolini ML; Bianconi F; Minestrini M; Nuvoli S; Tambasco N; Dottorini ME; Palumbo B Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935 [TBL] [Abstract][Full Text] [Related]
15. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms. Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424 [TBL] [Abstract][Full Text] [Related]
16. FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson's disease. Hubbuch M; Farmakis G; Schaefer A; Behnke S; Schneider S; Hellwig D; Fassbender K; Kirsch CM; Dillmann U; Spiegel J Eur Neurol; 2011; 65(4):187-92. PubMed ID: 21412004 [TBL] [Abstract][Full Text] [Related]
17. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease. Kaasinen V; Kinos M; Joutsa J; Seppänen M; Noponen T Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1931-7. PubMed ID: 24867256 [TBL] [Abstract][Full Text] [Related]
18. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. Qamhawi Z; Towey D; Shah B; Pagano G; Seibyl J; Marek K; Borghammer P; Brooks DJ; Pavese N Brain; 2015 Oct; 138(Pt 10):2964-73. PubMed ID: 26209314 [TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease. Moccia M; Pappatà S; Picillo M; Erro R; Coda AR; Longo K; Vitale C; Amboni M; Brunetti A; Capo G; Salvatore M; Barone P; Pellecchia MT J Neurol; 2014 Nov; 261(11):2112-8. PubMed ID: 25119838 [TBL] [Abstract][Full Text] [Related]
20. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]